P Dombernowsky

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.

P Dombernowsky, I E Smith, Geoffrey Falkson et al. · Journal of Clinical Oncology · 1998 · 640 citations

Medicine, Oncology, Pharmacology +16

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni, H. Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1997 · 481 citations

Medicine, Oncology, Pharmacology +14

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.

Jens Benn Sørensen, Heine H. Hansen, M Hansen et al. · Journal of Clinical Oncology · 1988 · 343 citations

Medicine, Oncology, Chemotherapy +13

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

M. Ryberg, Dorte Nielsen, Torben Skovsgaard et al. · Journal of Clinical Oncology · 1998 · 285 citations

Medicine, Oncology, Pharmacology +17

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

Ulrik Lassen, M Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1995 · 284 citations

Medicine, Oncology, Chemotherapy +12